As of November 2024, BioMarin Pharmaceutical has a market cap of $13.40B. This makes BioMarin Pharmaceutical the world's 1244th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $16.47B | -9.33% |
2023 | $18.16B | -6.83% |
2022 | $19.49B | 17.14% |
2021 | $16.64B | 0.75% |
2020 | $16.52B | 3.71% |
2019 | $15.93B | -0.70% |
2018 | $16.04B | -4.51% |
2017 | $16.80B | 7.64% |
2016 | $15.60B | -20.92% |
2015 | $19.73B | 15.88% |
2014 | $17.03B | 28.50% |
2013 | $13.25B | 42.99% |
2012 | $9.27B | 43.11% |
2011 | $6.48B | 27.66% |
2010 | $5.07B | 43.17% |
2009 | $3.54B | 5.67% |
2008 | $3.35B | -49.72% |
2007 | $6.67B | 115.99% |
2006 | $3.09B | 52.04% |
2005 | $2.03B | 68.70% |
2004 | $1.20B | -17.65% |
2003 | $1.46B | 10.07% |
2002 | $1.33B | -47.54% |
2001 | $2.53B | 38.74% |
2000 | $1.82B | -17.55% |
1999 | $2.21B | - |